Gut Microbiota and Associated Mucosal Immune Response in Eosinophilic Granulomatosis with Polyangiitis (EGPA)
暂无分享,去创建一个
A. Vaglio | A. Amedei | M. Ramazzotti | G. Bartolucci | E. Niccolai | G. Nannini | S. Baldi | E. Silvestri | G. Emmi | D. Prisco | A. Bettiol | F. Ricci | Leandro Di Gloria | F. Bello | M. Nicastro | L. Di Gloria
[1] A. Amedei,et al. The Gut Microbiota-Immunity Axis in ALS: A Role in Deciphering Disease Heterogeneity? , 2021, Biomedicines.
[2] A. Vaglio,et al. Occupational Exposures and Smoking in Eosinophilic Granulomatosis With Polyangiitis: A Case–Control Study , 2021, Arthritis & rheumatology.
[3] K. Davies,et al. Streptococcus-associated vasculitis: A role for antibiotic therapy? , 2021, IDCases.
[4] Brendan J. Kelly,et al. Dynamic Changes in the Nasal Microbiome Associated With Disease Activity in Patients With Granulomatosis With Polyangiitis , 2021, Arthritis & rheumatology.
[5] G. Emmi,et al. Eosinophilic Granulomatosis With Polyangiitis: Dissecting the Pathophysiology , 2021, Frontiers in Medicine.
[6] A. Kronbichler,et al. Nasal microbiome research in ANCA-associated vasculitis: Strengths, limitations, and future directions , 2020, Computational and structural biotechnology journal.
[7] F. Locatelli,et al. Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss). , 2020, Rheumatology.
[8] F. Sofi,et al. Butyrate Rich Diets Improve Redox Status and Fibrin Lysis in Behçet's Syndrome. , 2020, Circulation research.
[9] Alison H. Clifford,et al. An update on the microbiome in vasculitis , 2020, Current opinion in rheumatology.
[10] Y. Shoenfeld,et al. International Consensus on ANCA Testing in Eosinophilic Granulomatosis with Polyangiitis. , 2020, American journal of respiratory and critical care medicine.
[11] A. Vaglio,et al. Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management. , 2020, Rheumatology.
[12] A. Amedei,et al. The Link "Cancer and autoimmune diseases" in the light of microbiota: evidence of a potential culprit. , 2020, Immunology letters.
[13] M. Gulisano,et al. Faecal microbiota transplant from aged donor mice affects spatial learning and memory via modulating hippocampal synaptic plasticity- and neurotransmission-related proteins in young recipients , 2019, bioRxiv.
[14] William J. Astle,et al. Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status , 2019, Nature Communications.
[15] J. Parkhill,et al. The composition and functional protein subsystems of the human nasal microbiome in granulomatosis with polyangiitis: a pilot study , 2019, Microbiome.
[16] F. Stingo,et al. Evaluation and comparison of short chain fatty acids composition in gut diseases , 2019, World journal of gastroenterology.
[17] L. Svensson,et al. Microbiomes of Inflammatory Thoracic Aortic Aneurysms Due to Giant Cell Arteritis and Clinically Isolated Aortitis Differ From Those of Non-Inflammatory Aneurysms , 2019, Pathogens & immunity.
[18] L. Burkhardt,et al. Changes in the composition of the upper respiratory tract microbial community in granulomatosis with polyangiitis. , 2019, Journal of autoimmunity.
[19] P. Pandiyan,et al. Role of Short Chain Fatty Acids in Controlling Tregs and Immunopathology During Mucosal Infection , 2018, Front. Microbiol..
[20] P. Merkel,et al. Characterisation of the nasal microbiota in granulomatosis with polyangiitis , 2018, Annals of the rheumatic diseases.
[21] Robert C. Edgar,et al. Taxonomy annotation and guide tree errors in 16S rRNA databases , 2018, PeerJ.
[22] F. Cianchi,et al. The Different Functional Distribution of “Not Effector” T Cells (Treg/Tnull) in Colorectal Cancer , 2017, Front. Immunol..
[23] S. Yancey,et al. Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis , 2017, The New England journal of medicine.
[24] F. Cianchi,et al. Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease , 2016, Medicine.
[25] K. Adachi,et al. Th17 cells reflect colon submucosal pathologic changes in active eosinophilic granulomatosis with polyangiitis , 2015, BMC Immunology.
[26] M. Kuroda,et al. Characterization of the gut microbiota of Kawasaki disease patients by metagenomic analysis , 2015, Front. Microbiol..
[27] S. Turroni,et al. Dynamic efficiency of the human intestinal microbiota , 2015, Critical reviews in microbiology.
[28] S. Rampelli,et al. Behçet's syndrome patients exhibit specific microbiome signature. , 2015, Autoimmunity reviews.
[29] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[30] Y. Belkaid,et al. Role of the Microbiota in Immunity and Inflammation , 2014, Cell.
[31] S. Rampelli,et al. The Enterocyte-Associated Intestinal Microbiota of Breast-Fed Infants and Adults Responds Differently to a TNF-α-Mediated Pro-Inflammatory Stimulus , 2013, PloS one.
[32] M. Hattori,et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota , 2013, Nature.
[33] Yichun Hu,et al. Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population. , 2013, Arthritis and rheumatism.
[34] Y. Belkaid,et al. Effector and memory T cell responses to commensal bacteria. , 2013, Trends in immunology.
[35] Susan Holmes,et al. phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.
[36] Richard Hansen,et al. IBD—what role do Proteobacteria play? , 2012, Nature Reviews Gastroenterology &Hepatology.
[37] S. Mazmanian,et al. Pathobionts of the gastrointestinal microbiota and inflammatory disease. , 2011, Current opinion in immunology.
[38] F. Moosig,et al. CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome. , 2010, Arthritis and rheumatism.
[39] D A Bloch,et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). , 2010, Arthritis and rheumatism.
[40] Hadley Wickham,et al. ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .
[41] M. D’Elios,et al. Moraxella Catarrhalis-Specific Th1 Cells in Bal Fluids of Chronic Obstructive Pulmonary Disease Patients , 2009, International journal of immunopathology and pharmacology.
[42] David Steven Scott,et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3) , 2008, Annals of the rheumatic diseases.
[43] U. Maggiore,et al. HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. , 2007, Arthritis and rheumatism.
[44] L. Cosmi,et al. Phenotypic and functional features of human Th17 cells , 2007, The Journal of experimental medicine.
[45] M. De Vos,et al. Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy , 2001, Annals of the rheumatic diseases.
[46] W. Gross,et al. Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome. , 2001, Arthritis and rheumatism.
[47] N. Barnich,et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. , 1998, Gastroenterology.
[48] M. Sanak,et al. Both Th2 and Th17 responses are involved in the pathogenesis of Churg-Strauss syndrome. , 2011, Clinical and experimental rheumatology.
[49] B. Finlay,et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. , 2007, Cell host & microbe.
[50] M. Sanak,et al. Both Th 2 and Th 17 responses are involved in the pathogenesis of Churg-Strauss syndrome , 2006 .
[51] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .